Cargando…
A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells
BACKGROUND: T-cell activation leads to signaling pathways that ultimately result in induction of gene transcription from the interleukin-2 (IL-2) promoter. We hypothesized that the IL-2 promoter or its synthetic derivatives can lead to T-cell specific, activation-induced transgene expression. Our ob...
Autores principales: | Jaalouk, Diana E, Lejeune, Laurence, Couture, Clément, Galipeau, Jacques |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1679806/ https://www.ncbi.nlm.nih.gov/pubmed/17118192 http://dx.doi.org/10.1186/1743-422X-3-97 |
Ejemplares similares
-
Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors
por: Jaalouk, Diana E, et al.
Publicado: (2006) -
New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines
por: Albagli, Olivier, et al.
Publicado: (2019) -
Retrovectors packaged in CHO cells to generate GLP-1-Fc stable expression CHO cell lines
por: Li, Jing, et al.
Publicado: (2019) -
Rexin-G(®), a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report
por: Kim, Seth, et al.
Publicado: (2017) -
A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer
por: Chawla, Sant P., et al.
Publicado: (2018)